Atlas Trials

Study of T Cells Targeting CD138/BCMA/CD19/More Antigens (CART-138/BCMA/19/More) for Chemotherapy Refractory and Relapsed Multiple Myeloma

Clinical trial NCT03196414 · RECRUITING

Trial details

NCT number
NCT03196414
Sponsor
The First Affiliated Hospital of Soochow University
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2016-09-01
Primary completion
2026-09-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.